FDA reviewers didn’t get to vote on first priority voucher drug
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
We’re reading about Trump and patent policies, a new malaria drug
Top of the morning to you, and a fine one it is. Blue skies and comfortable breezes are…
UnitedHealthcare drops remote monitoring coverage
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Children’s Health Defense builds power base to outlast RFK Jr.
WASHINGTON — Children’s Health Defense, the vaccine-skeptical organization once led by now-health secretary Robert F. Kennedy Jr., is…
CRISPR gene editing therapy cuts LDL cholesterol in small study
A CRISPR-based gene editing therapy dramatically reduced levels of low-density lipoprotein, often called “bad cholesterol,” and triglycerides in…
Amgen’s Repatha cholesterol shot slashed heart attack risk by 36%
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach…
Medicare picks tech firms to run prior authorization pilot
The Centers for Medicare and Medicaid Services has selected the six technology companies that will administer artificial intelligence-powered…
Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s Stelara
In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
New FDA priority review vouchers go to Lilly, Novo, Vertex
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
TrumpRx to offer discount weight loss drugs after Lilly, Novo deals
WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by…